MedPath

The effect of Letrozole on pregnancy rate in women with polycystic ovary syndrome

Phase 3
Recruiting
Conditions
Female infertility.
Female infertility
Registration Number
IRCT20081007001306N12
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
124
Inclusion Criteria

All infertile women with polycystic ovary syndrome resistant to letrozole primary treatment
With full consent to participate in the study
Under the age of 35
There is an indication for the use of oral medication (not received 6 cycles of ovulation induction medication)

Exclusion Criteria

Obstruction of the fallopian tubes
Absence of a healthy uterine cavity
Ovarian cysts
Metabolic diseases and any disease that has a negative effect on ovulation
Chronic heart, liver and kidney diseases
Abnormal sperm analysis
Using other ovulation induction drugs at the same time

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath